Source link : https://www.newshealth.biz/health-news/ema-broadens-imvanex-vaccine-use-to-teens-as-mpox-cases-rise/
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended extending the indication of the smallpox and mpox vaccine Imvanex to adolescents aged 12-17 years. The vaccine is already authorized in the European Union to protect against smallpox, mpox, and the disease caused by vaccinia virus in adults. Mpox is […]
Author : News Health
Publish date : 2024-09-20 09:09:36
Copyright for syndicated content belongs to the linked Source.